SUBSCRIBE
SUBSCRIBE

Grifols

NEWS
Job Trends
Biopharma Companies Continue to Expand, Add Jobs Despite Ongoing Pandemic
Amidst the pandemic, the biopharma industry continues to surge ahead. Jobs look plentiful. Check out these companies that have made recent job announcement expansions.
June 30, 2020
 · 
5 min read
 · 
Ellen Bombela
Drug Development
Biotech Bay Companies Fighting Against COVID-19
Biotech Bay, the bustling biotech industry around San Francisco in California, is home to many biopharma companies developing diagnostics, therapies, and vaccines to fight against coronavirus disease 2019 (COVID-19) and the virus that causes it, called SARS-CoV-2.
May 22, 2020
 · 
11 min read
 · 
Chelsea Weidman Burke, M.S.
J&J’s Ethicon and Spain’s Grifols Release 1st Product Out of 10-Year Collaboration Deal
The sealant was developed by Grifols and combines two plasma proteins, fibrinogen and thrombin. The spray is administered with New Jersey-based Ethicon’s airless spray device.
June 20, 2019
 · 
3 min read
 · 
Mark Terry
Load More
JOBS
IN THE PRESS
Biotech Bay
GigaGen Granted Expansion of Contract with US Department of Defense to Develop Synthetic Human Antibody Treatments for Botulinum Neurotoxins
October 19, 2023
 · 
6 min read
Biotech Bay
GigaGen Partners with the National Cancer Institute to Advance Oncology Drug Candidate GIGA-564
September 28, 2023
 · 
7 min read
Drug Development
Grifols Achieves Positive Topline Results From Phase 4 Study of XEMBIFY® (immune globulin subcutaneous human-klhw) Evaluating Biweekly Dosing Option for Patients
July 20, 2023
 · 
10 min read
Drug Development
Grifols Meets Enrollment Target in Phase 3 Study of Two Dose Regimens of Prolastin®-C in Patients with Emphysema Due to Alpha-1-Antitrypsin Deficiency
July 13, 2023
 · 
8 min read
Drug Development
Grifols Launches AlphaID™ At Home, Enabling U.S. Consumers to Self-Screen for Genetic COPD
May 11, 2023
 · 
7 min read
Policy
Grifols 2022 Annual Report on Form 20-F filed with the SEC on April 18, 2023
April 18, 2023
 · 
5 min read
Business
Selagine Enters into a Collaborative Agreement with Grifols for Development and Commercialization of Immunoglobulin Eye Drops for Treating Dry Eye Disease
March 6, 2023
 · 
6 min read
Business
Victor Grifols Roura decides to retire as Chairperson; Grifols appoints private equity veteran Steven F. Mayer as Executive Chairperson
October 3, 2022
 · 
9 min read
Biotech Bay
GigaGen Publishes Research Demonstrating the Potential of its Machine Learning Platform to Improve Antibody Drug Discovery and Development
May 19, 2022
 · 
5 min read
Policy
Grifols 2021 Annual Report on Form 20-F filed with the SEC on April 29, 2022
April 29, 2022
 · 
2 min read
Load More